FDA approves first generic capecitabine to treat breast and colorectal cancers

Author(s):

On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic breast and colorectal cancer. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here